1. Home
  2. ASPN vs ZURA Comparison

ASPN vs ZURA Comparison

Compare ASPN & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

N/A

Current Price

$5.51

Market Cap

407.5M

ML Signal

N/A

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$4.14

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASPN
ZURA
Founded
2001
2022
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.5M
455.4M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
ASPN
ZURA
Price
$5.51
$4.14
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$7.75
★ $18.00
AVG Volume (30 Days)
794.5K
★ 1.5M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $271,103,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$30.02
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.30
$3.15
52 Week High
$9.35
$7.25

Technical Indicators

Market Signals
Indicator
ASPN
ZURA
Relative Strength Index (RSI) 59.02 32.37
Support Level $5.25 $3.90
Resistance Level $5.60 $5.87
Average True Range (ATR) 0.26 0.29
MACD 0.05 -0.06
Stochastic Oscillator 81.48 18.75

Price Performance

Historical Comparison
ASPN
ZURA

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: